Analystreport

Vascular Biogenics Ltd. (NASDAQ: VBLT) had its price target raised by analysts at Roth Capital from $5.00 to $7.00. They now have a "buy" rating on the stock.

Vascular Biogenics Ltd. - Ordinary Shares  (VBLT) 
Last vascular biogenics ltd. - ordinary shares earnings: 11/14 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: vblrx.com